We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

302 hedge funds and large institutions have $4.58B invested in Bio-Rad Laboratories Class A in 2017 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 101 increasing their positions, 102 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 24

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

11% more funds holding

Funds holding: 271 → 302 (+31)

7% more capital invested

Capital invested by funds: $4.27B → $4.58B (+$318M)

0.34% less ownership

Funds ownership: 78.25% → 77.91% (-0.34%)

1% less repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 102

74% less call options, than puts

Call options by funds: $2.1M | Put options by funds: $8.14M

Holders
302
Holders Change
+31
Holders Change %
+11.44%
% of All Funds
6.85%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.16%
New
57
Increased
101
Reduced
102
Closed
24
Calls
$2.1M
Puts
$8.14M
Net Calls
-$6.04M
Net Calls Change
-$7.55M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$52M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$30.2M
3
SC
Samlyn Capital
New York
+$25.3M
4
PC
Polar Capital
United Kingdom
+$23.7M
5
Millennium Management
Millennium Management
New York
+$23.1M

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$62.2M
2
Bank of America
Bank of America
North Carolina
-$46.9M
3
CRM
Cramer Rosenthal McGlynn
Connecticut
-$41.4M
4
ACM
Atlanta Capital Management
Georgia
-$24.4M
5
NFA
Nationwide Fund Advisors
Ohio
-$21.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CTA
301
Carillon Tower Advisers
Florida
$582 +$592K +2,442 New
PCG
302
Private Capital Group
Connecticut
$3 +$2.91K +12 New
NFA
303
Nationwide Fund Advisors
Ohio
– -$21.4M -96,138 Closed
CA
304
Claar Advisors
New York
– -$13.3M -60,000 Closed
SAM
305
Sentinel Asset Management
Vermont
– -$12.8M -57,477 Closed
SI
306
Sapience Investments
California
– -$6.3M -28,365 Closed
PVI
307
Pura Vida Investments
New York
– -$6.22M -28,000 Closed
LOAMU
308
Lombard Odier Asset Management (USA)
New York
– -$3.33M -15,000 Closed
Wellington Management Group
309
Wellington Management Group
Massachusetts
– -$906K -4,076 Closed
PP
310
Paloma Partners
Connecticut
– -$746K -3,358 Closed
HHC
311
Hutchin Hill Capital
New York
– -$667K -3,000 Closed
SEC
312
Seven Eight Capital
New York
– -$556K -2,500 Closed
FA
313
FDx Advisors
Illinois
– -$407K -1,832 Closed
NI
314
Numeric Investors
Massachusetts
– -$333K -1,500 Closed
Capstone Investment Advisors
315
Capstone Investment Advisors
New York
– -$288K -1,300 Closed
TH
316
Timber Hill
Connecticut
– -$214K -963 Closed
NIMI
317
Natixis Investment Managers International
France
– -$140K -632 Closed
GT
318
Glenmede Trust
Pennsylvania
– -$122K -554 Closed
PG
319
PEAK6 Group
Illinois
– -$109K -449 Closed
AIL
320
AGF Investments LLC
Ontario, Canada
– -$53K -234 Closed
PHK
321
Point72 Hong Kong
Hong Kong
– -$43K -194 Closed
CMBA
322
C.M. Bidwell & Associates
Hawaii
– -$36K -160 Closed
Carson Wealth (CWM LLC)
323
Carson Wealth (CWM LLC)
Nebraska
– -$3K -12 Closed
DAM
324
Delta Asset Management
Tennessee
– -$2K -8 Closed
LWCFA
325
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$1K -6 Closed
10 11 12
13
14

BIO Hedge Fund Activity: Q4 2017 in Review

302 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2017, worth a combined $4.58B — up 7.5% from $4.27B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new BIO positions and 24 closed out — a net gain of 33 holders — while 101 added to existing stakes and 102 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $52M. The largest seller was Ariel Investments, cutting an estimated $62.2M.

  • 302 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2017, up from 271 in Q3 2017.
  • Funds reported $4.58B of Bio-Rad Laboratories Class A stock for Q4 2017, up 7.5% quarter-over-quarter.
  • 57 funds opened new Bio-Rad Laboratories Class A positions in Q4 2017 and 24 closed out, a net change of +33 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2017 was Renaissance Technologies, an estimated $52M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2017 was Ariel Investments, an estimated $62.2M sold.

Based on aggregated 13F filings for Q4 2017.